Estados financieros detallados de Hoth Therapeutics, Inc. (HOTH): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.80, HOTH presenta beneficios negativos (P/E no significativo) y un ROE del -202.73%. La capitalización bursátil es de $11M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $188 | $28252 | $31622 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$188 | -$28252 | -$31622 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $586843 | $1.0M | $2.1M | $2.9M | $7.5M | $4.9M | $3.5M | $3.2M | $5.9M |
| Generales y Administrativos | $1.3M | $1.2M | $5.1M | $4.4M | $6.6M | $6.1M | $4.2M | $5.0M | $6.4M |
| Gastos Operativos | $1.9M | $2.5M | $7.7M | $7.3M | $14.1M | $11.1M | $7.7M | $8.2M | $11.1M |
| Beneficio Operativo | -$1.9M | -$2.5M | -$7.7M | -$7.3M | -$14.1M | -$11.1M | -$7.7M | -$8.2M | -$11.1M |
| EBITDA | -$2.0M | -$2.5M | -$7.7M | -$7.3M | -$14.3M | -$990 | -$153149 | $27132 | -$12.5M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | $305409 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.0M | -$2.5M | -$7.7M | -$7.2M | -$14.3M | -$11.4M | -$7.8M | -$8.2M | -$12.5M |
| Impuestos | $2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.0M | -$2.5M | -$7.7M | -$7.2M | -$14.3M | -$11.4M | -$7.8M | -$8.2M | -$12.5M |
| BPA | $-5.24 | $-6.62 | $-20.99 | $-14.56 | $-16.03 | $-9.50 | $-2.30 | $-1.28 | $-0.90 |
| BPA Diluido | $-5.24 | $-6.62 | $-20.99 | $-14.56 | $-16.03 | $-9.50 | $-2.30 | $-1.28 | $-0.90 |
| Acciones en Circulación (Diluidas) | $384482 | $376982 | $366583 | $494513 | $893203 | $1.2M | $3.4M | $6.4M | $13.8M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.2M | $282621 | $1.7M | $2.6M | $8.5M | $6.4M | $9.3M | $7.0M | $6.2M |
| Inversiones a Corto | 0 | 0 | $803664 | $2.1M | $1.9M | $209320 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $50000 | 0 | 0 | $46769 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.2M | $501648 | $2.6M | $4.8M | $10.6M | $6.7M | $10.2M | $7.6M | $6.9M |
| Inmovilizado Material | $3492 | $2268 | $1043 | 0 | 0 | 0 | $55165 | $31075 | $4652 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $1.2M | $503916 | $2.8M | $5.2M | $11.0M | $6.8M | $10.2M | $7.7M | $7.6M |
| Cuentas por Pagar | $47924 | $142280 | $403885 | $129469 | $360964 | $694989 | $35592 | $412071 | $823674 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $49466 | $348951 | $440121 | $312149 | $867787 | $1.4M | $678657 | $831197 | $1.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $49466 | $348951 | $440121 | $597149 | $1.1M | $1.6M | $704983 | $833906 | $1.5M |
| Reservas | -$2.0M | -$4.5M | -$12.2M | -$19.4M | -$33.7M | -$45.1M | -$52.2M | -$60.4M | -$72.9M |
| Patrimonio Neto | $1.2M | $154965 | $2.4M | $4.6M | $9.9M | $5.1M | $9.5M | $6.9M | $6.2M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | 0 | $55165 | $31075 | $5678 |
| Deuda Neta | -$1.2M | -$282621 | -$2.5M | -$4.7M | -$10.4M | -$6.6M | -$9.2M | -$7.0M | -$6.2M |
| Capital Circulante | $1.2M | $152697 | $2.2M | $4.5M | $9.7M | $5.3M | $9.5M | $6.8M | $5.4M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$2.0M | -$2.5M | -$7.7M | -$7.2M | -$14.3M | -$11.4M | -$8.1M | -$8.2M | -$12.5M |
| Amortizaciones | $188 | $1224 | $1225 | $1043 | 0 | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.5M | $143053 | $2.5M | $737746 | $1.3M | $620798 | $216428 | $804277 | $1.2M |
| Cambio en Capital Circulante | $49466 | $80458 | $169641 | -$131752 | $529920 | $594479 | -$487320 | $405191 | $184146 |
| Flujo de Caja Operativo | -$465243 | -$2.1M | -$4.9M | -$6.1M | -$12.1M | -$9.3M | -$8.4M | -$7.0M | -$9.8M |
| Inversiones (CapEx) | -$303680 | 0 | -$95000 | -$167457 | -$116970 | -$74000 | $4 | $1 | -$2 |
| Adquisiciones | 0 | 0 | 0 | -$410000 | $116970 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | $132164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$768923 | -$2.1M | -$5.0M | -$6.3M | -$12.2M | -$9.4M | -$8.4M | -$7.0M | -$9.8M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -23.8% | -208.3% | +6.5% | -98.9% | +20.6% | +31.0% | -4.4% | -52.3% | |
| Crecimiento BPA (anual) | -26.3% | -217.1% | +30.6% | -10.1% | +40.7% | +75.8% | +44.3% | +29.7% | |
| Cambio en Acciones (anual) | -2.0% | -2.8% | +34.9% | +80.6% | +34.1% | +184.7% | +87.0% | +116.6% | |
| Crecimiento FCF (anual) | -173.5% | -139.8% | -25.0% | -93.7% | +23.2% | +9.9% | +17.4% | -40.5% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.00 | $-5.58 | $-13.75 | $-12.74 | $-13.67 | $-7.83 | $-2.48 | $-1.09 | $-0.71 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $384482 | $376982 | $366583 | $494513 | $893203 | $1.2M | $3.4M | $6.4M | $13.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -202.73% |
| Rentabilidad sobre capital invertido | -180.48% |
| Rentabilidad sobre activos | -164.00% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 4.72 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.74 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| P/E | -40.70 | -32.21 | -7.37 | -4.07 | -1.03 | -0.82 | -0.63 | -0.58 | -1.10 |
| P/VC | 69.22 | 518.77 | 23.68 | 6.31 | 1.49 | 1.82 | 0.51 | 0.69 | 2.22 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ASBP · BCTX · CRIS · DARE · ENTO · FBLG · LEXX
Explorar sector: Healthcare · Biotechnology
Más secciones de HOTH: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones